Association of STAT4 with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in the Japanese population

…, Y Nakamura, Y Toyama, T Mochizuki… - … : Official Journal of …, 2008 - Wiley Online Library
Objective STAT4 encodes a transcriptional factor that transmits signals induced by several
key cytokines, and it might be a key molecule in the development of autoimmune diseases. …

Sarcopenia‐associated factors in Japanese patients with rheumatoid arthritis: A cross‐sectional study

T Mochizuki, K Yano, K Ikari… - Geriatrics & gerontology …, 2019 - Wiley Online Library
Aim To evaluate the prevalence rate and factors associated with sarcopenia in Japanese
patients with rheumatoid arthritis. Methods We enrolled 240 consecutive patients with …

Long-term deterioration of interstitial lung disease in patients with rheumatoid arthritis treated with abatacept

T Mochizuki, K Ikari, K Yano, M Sato… - Modern …, 2019 - academic.oup.com
Objective: To examine the deterioration of interstitial lung disease (ILD) in patients with
rheumatoid arthritis (RA) treated with abatacept over the long-term. Methods: We examined 131 …

Is minimally invasive surgery in total knee arthroplasty really minimally invasive surgery?

Y Niki, T Mochizuki, S Momohara, S Saito… - The Journal of …, 2009 - Elsevier
Minimization of soft-tissue damage is one of the primary purposes behind the application of
minimally invasive surgery (MIS) in total knee arthroplasty (TKA). A consecutive series of 147 …

[HTML][HTML] Features of patients with rheumatoid arthritis whose debut joint is a foot or ankle joint: a 5,479-case study from the IORRA cohort

K Yano, K Ikari, E Inoue, Y Sakuma, T Mochizuki… - PLoS …, 2018 - journals.plos.org
Background Foot and ankle joint disorders are serious issues for patients with rheumatoid
arthritis (RA). We compared the differences between patients with RA whose first symptom …

Rheumatoid arthritis: a risk factor for deep venous thrombosis after total knee arthroplasty? Comparative study with osteoarthritis

Y Niki, H Matsumoto, A Hakozaki, T Mochizuki… - Journal of Orthopaedic …, 2010 - Springer
Background Recent advances in the understanding of blood coagulation processes favor
an inflammatory basis for thrombotic events. In this study, thrombotic risk after total knee …

Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year outcome of …

…, E Sato, H Kameda, S Iwata, T Mochizuki… - Modern …, 2008 - academic.oup.com
The anti-TNF-α chimeric monoclonal antibody infliximab is the first biologic to be approved
for rheumatoid arthritis (RA) in Japan, and post-marketing surveillance of all of the Japanese …

[HTML][HTML] Effects of romosozumab or denosumab treatment on the bone mineral density and disease activity for 6 months in patients with rheumatoid arthritis with …

T Mochizuki, K Yano, K Ikari, K Okazaki - Osteoporosis and sarcopenia, 2021 - Elsevier
Objectives To investigate effects of romosozumab treatment on disease activity and bone
mineral density (BMD) in patients with rheumatoid arthritis (RA) and severe osteoporosis in …

Comparison of romosozumab versus denosumab treatment on bone mineral density after 1 year in rheumatoid arthritis patients with severe osteoporosis: a …

T Mochizuki, K Yano, K Ikari, R Hiroshima… - Modern …, 2023 - academic.oup.com
Objectives To investigate the effect of romosozumab versus denosumab treatment on bone
mineral density (BMD), disease activity, and joint damage in patients with rheumatoid arthritis …

Effects of denosumab treatment on bone mineral density and joint destruction in patients with rheumatoid arthritis

T Mochizuki, K Yano, K Ikari, K Kawakami… - Journal of Bone and …, 2018 - Springer
We aimed to investigate the efficacy of denosumab for rheumatoid arthritis (RA). This study
enrolled 70 RA patients who received denosumab 60 mg subcutaneous injection at baseline …